PFS Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.3K | Hold |
158
| – | – | 0.04% | 136 |
|
|
2025
Q1 | $76.6K | Hold |
158
| – | – | 0.04% | 116 |
|
|
2024
Q4 | $63.6K | Hold |
158
| – | – | 0.03% | 128 |
|
|
2024
Q3 | $73.5K | Hold |
158
| – | – | 0.04% | 106 |
|
|
2024
Q2 | $74.1K | Hold |
158
| – | – | 0.05% | 104 |
|
|
2024
Q1 | $66K | Hold |
158
| – | – | 0.04% | 105 |
|
|
2023
Q4 | $64.3K | Hold |
158
| – | – | 0.04% | 111 |
|
|
2023
Q3 | $54.9K | Hold |
158
| – | – | 0.05% | 96 |
|
|
2023
Q2 | $55.6K | Buy |
158
+39
| +33% | +$13.7K | 0.05% | 99 |
|
|
2023
Q1 | $37.5K | Hold |
119
| – | – | 0.04% | 109 |
|
|
2022
Q4 | $34.4K | Buy |
+119
| New | +$34.4K | 0.04% | 108 |
|